mothertobaby semaglutide pregnancy fact sheet 2025 | agonist of glucagon-like peptide-1 (GLP-1) receptor | CAS 910463-68-2 | NNC 0113-0217; NNC-0113-0217; Ozempic | long-acting GLP-1 analogue Weighing In: How GLP-1s Fit

Candice Fraser is an OB/GYN practitioner and founder of Trinity Medical Care

Gastrointestinal side effects associated with semaglutide typically occur more frequently during the initial weeks of treatment or following dose escalation

Semaglutide addresses what thyroid medication can't

Clinical trials have consistently demonstrated the efficacy of semaglutide in promoting weight loss, making it a promising tool for obesity management

A 503(a) pharmacy is a traditional compounding pharmacy that compounds medications for individual prescriptions from a licensed prescriber

The dosage is increased in 2.5 mg increments every 4 weeks until reaching the maximum tolerated dose